This is the first time that HAS is issuing a favorable opinion for the reimbursement of a technology...
Read moreWe explore joint scientific consultations; what they mean and why they are important to manufacturer...
Read moreWindsor Framework replaces the Northern Ireland protocol to address issues and provide significant c...
Read moreUsing Early Access Programs (EAPs) to give patients with life threatening conditions access to medic...
Read moreOur Market Access experts investigate what early access opportunities are available in China to enab...
Read moreThe provision of funding for Early Access Programmes is not ubiquitous. We explore which EU5 countri...
Read morePayer value proposition development and understanding evidence requirements to secure pricing and re...
Read moreAlmost a decade after it's inception, what have we learned from the UK early access to medicines sch...
Read moreMHRA announces UK will introduce new framework aimed at making the manufacture of innovative medicin...
Read moreWe summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...
Read more